Creative Planning’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83M | Sell |
84,188
-11,029
| -12% | -$213K | ﹤0.01% | 1965 |
|
|
2025
Q4 | $2.05M | Buy |
95,217
+58,139
| +157% | +$1.23M | ﹤0.01% | 1714 |
|
|
2025
Q3 | $714K | Buy |
+37,078
| New | +$661K | ﹤0.01% | 2417 |
|
|
2025
Q2 | – | Sell |
-7,986
| Closed | -$510K | – | 3787 |
|
|
2025
Q1 | $510K | Sell |
7,986
-882
| -10% | -$92.8K | ﹤0.01% | 2266 |
|
|
2024
Q4 | $1.08M | Buy |
8,868
+1,191
| +16% | +$146K | ﹤0.01% | 1595 |
|
|
2024
Q3 | $959K | Sell |
7,677
-260
| -3% | -$35.9K | ﹤0.01% | 1543 |
|
|
2024
Q2 | $1.25M | Buy |
7,937
+829
| +12% | +$106K | ﹤0.01% | 1261 |
|
|
2024
Q1 | $920K | Buy |
7,108
+1,104
| +18% | +$135K | ﹤0.01% | 1392 |
|
|
2023
Q4 | $579K | Sell |
6,004
-17,159
| -74% | -$1.65M | ﹤0.01% | 1602 |
|
|
2023
Q3 | $2.8M | Buy |
23,163
+665
| +3% | +$75.2K | ﹤0.01% | 712 |
|
|
2023
Q2 | $2.58M | Buy |
22,498
+162
| +0.7% | +$20.9K | ﹤0.01% | 717 |
|
|
2023
Q1 | $3.08M | Buy |
22,336
+395
| +2% | +$51.2K | ﹤0.01% | 635 |
|
|
2022
Q4 | $2.84M | Buy |
21,941
+298
| +1% | +$34.5K | ﹤0.01% | 638 |
|
|
2022
Q3 | $2.39M | Sell |
21,643
-472
| -2% | -$47.6K | ﹤0.01% | 639 |
|
|
2022
Q2 | $1.66M | Sell |
22,115
-1
| -0% | -$74 | ﹤0.01% | 780 |
|
|
2022
Q1 | $1.73M | Sell |
22,116
-5
| -0% | -$383 | ﹤0.01% | 761 |
|
|
2021
Q4 | $1.99M | Sell |
22,121
-1,253
| -5% | -$107K | ﹤0.01% | 690 |
|
|
2021
Q3 | $2.16M | Sell |
23,374
-3,588
| -13% | -$276K | ﹤0.01% | 661 |
|
|
2021
Q2 | $2.1M | Sell |
26,962
-5,615
| -17% | -$426K | ﹤0.01% | 666 |
|
|
2021
Q1 | $2.43M | Sell |
32,577
-2,806
| -8% | -$259K | ﹤0.01% | 644 |
|
|
2020
Q4 | $6.03M | Buy |
35,383
+753
| +2% | +$112K | 0.01% | 335 |
|
|
2020
Q3 | $4.86M | Buy |
34,630
+6,823
| +25% | +$1.04M | 0.01% | 315 |
|
|
2020
Q2 | $4.46M | Buy |
27,807
+420
| +2% | +$57.2K | 0.01% | 302 |
|
|
2020
Q1 | $2.68M | Sell |
27,387
-32,501
| -54% | -$3.72M | 0.01% | 355 |
|
|
2019
Q4 | $7.73M | Buy |
59,888
+7,563
| +14% | +$763K | 0.02% | 234 |
|
|
2019
Q3 | $3.94M | Sell |
52,325
-57,465
| -52% | -$6.79M | 0.01% | 335 |
|
|
2019
Q2 | $16.7M | Sell |
109,790
-19,900
| -15% | -$2.42M | 0.06% | 128 |
|
|
2019
Q1 | $15.5M | Buy |
129,690
+59,487
| +85% | +$7.65M | 0.06% | 125 |
|
|
2018
Q4 | $7.66M | Sell |
70,203
-9,224
| -12% | -$1.15M | 0.03% | 182 |
|
|
2018
Q3 | $12.8M | Buy |
79,427
+8,280
| +12% | +$1.13M | 0.05% | 140 |
|
|
2018
Q2 | $9.4M | Sell |
71,147
-15,703
| -18% | -$1.48M | 0.04% | 162 |
|
|
2018
Q1 | $6.43M | Sell |
86,850
-11,833
| -12% | -$789K | 0.03% | 201 |
|
|
2017
Q4 | $5.49M | Sell |
98,683
-5,073
| -5% | -$269K | 0.02% | 224 |
|
|
2017
Q3 | $4.71M | Sell |
103,756
-3,344
| -3% | -$134K | 0.02% | 251 |
|
|
2017
Q2 | $3.61M | Sell |
107,100
-4,025
| -4% | -$131K | 0.02% | 280 |
|
|
2017
Q1 | $3.29M | Buy |
111,125
+11,800
| +12% | +$365K | 0.02% | 291 |
|
|
2016
Q4 | $2.72M | Buy |
99,325
+53,625
| +117% | +$2.15M | 0.02% | 321 |
|
|
2016
Q3 | $2.81M | Sell |
45,700
-20,000
| -30% | -$605K | 0.02% | 306 |
|
|
2016
Q2 | $1.25M | Buy |
65,700
+11,550
| +21% | +$214K | 0.01% | 456 |
|
|
2016
Q1 | $1.06M | Buy |
54,150
+1,200
| +2% | +$21K | 0.01% | 487 |
|
|
2015
Q4 | $2.04M | Buy |
52,950
+25,900
| +96% | +$840K | 0.02% | 307 |
|
|
2015
Q3 | $869K | Sell |
27,050
-1,500
| -5% | -$50.9K | 0.01% | 519 |
|
|
2015
Q2 | $869K | Buy |
28,550
+6,500
| +29% | +$133K | 0.01% | 510 |
|
|
2015
Q1 | $293K | Buy |
22,050
+4,000
| +22% | +$53.3K | ﹤0.01% | 1003 |
|
|
2014
Q4 | $261K | Buy |
18,050
+7,800
| +76% | +$132K | ﹤0.01% | 998 |
|
|
2014
Q3 | $216K | Buy |
10,250
+4,400
| +75% | +$99.3K | ﹤0.01% | 1020 |
|
|
2014
Q2 | $174K | Buy |
5,850
+50
| +0.9% | +$1.58K | ﹤0.01% | 1104 |
|
|
2014
Q1 | $139K | Buy |
5,800
+5,034
| +657% | +$128K | ﹤0.01% | 1192 |
|
|
2013
Q4 | $16K | Buy |
766
+700
| +1,061% | +$20.8K | ﹤0.01% | 2323 |
|
|
2013
Q3 | $3K | Hold |
66
| – | – | ﹤0.01% | 2911 |
|
|
2013
Q2 | $3K | Buy |
+66
| New | +$2.36K | ﹤0.01% | 2738 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
Creative Planning's SRPT Position: Q1 2026 in Review
Creative Planning reduced its Sarepta Therapeutics (SRPT) stake by 12% in Q1 2026, selling an estimated $213K and leaving 84,188 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1965.
Creative Planning first reported a position in SRPT in Q2 2013 and has held it in 51 quarters since. The position peaked at $16.7M in Q2 2019. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.
- Creative Planning held 84,188 shares of Sarepta Therapeutics worth $1.83M as of Q1 2026.
- Creative Planning sold 11,029 Sarepta Therapeutics shares in Q1 2026, an estimated $213K.
- Sarepta Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1965 holding.
- Creative Planning first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 51 quarters since.
- Creative Planning's Sarepta Therapeutics position peaked at $16.7M in Q2 2019.
- 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.